Society of Critical Care Medicine Guidelines on Glycemic Control for Critically Ill Children and Adults 2024: Executive Summary
- PMID: 38240482
- DOI: 10.1097/CCM.0000000000006173
Society of Critical Care Medicine Guidelines on Glycemic Control for Critically Ill Children and Adults 2024: Executive Summary
Conflict of interest statement
Dr. Umpierrez’s institution received funding from Dexcom, Abbott, Bayer, and Astra Zeneca. Dr. Sirimaturos’ institution received funding from Grifols; he received funding from Astra Zeneca. Dr. Mechanick received funding from Abbott Nutrition, Aveta.Life, and Twin Health. Dr. Irving disclosed that she is an American Society of Parenteral and Enteral Nutrition (ASPEN) board member and author on Society of Critical Care Medicine/ASPEN guidelines for pediatric nutrition support. Dr. Preiser received funding from Edwards, Glysure, Medtronic, and Optiscan. Dr. Krinsley received funding from Dexcom. Dr. Sands received funding from BioXcel Therapeutics. Dr. Jacobi disclosed that she is an Advisory Board Member of the Pfizer Hospital Business Unit. Dr. Agus’ institution received funding from the National Institutes of Health; he disclosed that Dexcom is providing in kind support with continuous glucose monitors for a clinical trial in children. The remaining authors have disclosed that they do not have any potential conflicts of interest.
References
-
- ElSayed NA, Aleppo G, Aroda VR, et al.; on behalf of the American Diabetes Association: American Diabetes Association 16. Diabetes care in the hospital: Standards of care in diabetes—2023. Diabetes Care 2023; 46(Suppl 1):S267–S278
-
- Blonde L, Umpierrez GE, Reddy SS, et al.: American Association of Clinical Endocrinology clinical practice guidelines: Developing a diabetes mellitus comprehensive care plan—2022 update. Endo Pract 2022; 28:923–1049
-
- Honarmand K, Sirimaturos M, Hirshberg EL, et al.: Society of Critical Care Medicine guidelines on glycemic control for critically ill children and adults. Crit Care Med 2024; 52:e161–e181
-
- Jacobi J, Bircher N, Krinsley J, et al.: Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med 2012; 40:3251–3276
-
- van den Berghe G, Wouters P, Weekers F, et al.: Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359–1367
MeSH terms
LinkOut - more resources
Full Text Sources